MFDS — authorised 11 July 2016
- Marketing authorisation holder: SHIRE DEV LLC
- Status: likely_approved
🇰🇷 Xiidra in South Korea
MFDS authorised Xiidra on 11 July 2016
Marketing authorisation
Xiidra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Xiidra approved in South Korea?
Yes. MFDS authorised it on 11 July 2016.
Who is the marketing authorisation holder for Xiidra in South Korea?
SHIRE DEV LLC holds the South Korean marketing authorisation.